Lineage Cell Therapeutics In shares owned by Beirne Wealth Consulting Services
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Beirne Wealth Consulting Services
from 13F filings
Historical chart of Beirne Wealth Consulting Services investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Beirne Wealth Consulting Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Beirne Wealth Consulting Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $49k | 45k | 1.09 |
| 2023-09-30 | $64k | 45k | 1.41 |
| 2023-06-30 | $64k | 45k | 1.41 |
| 2023-03-31 | $68k | 45k | 1.50 |
| 2022-12-31 | $53k | 45k | 1.17 |
| 2022-09-30 | $51k | 45k | 1.13 |
| 2022-06-30 | $71k | 45k | 1.58 |
| 2022-03-31 | $70k | 45k | 1.56 |
| 2021-12-31 | $110k | 45k | 2.44 |
| 2021-09-30 | $113k | 45k | 2.51 |
| 2021-06-30 | $128k | 45k | 2.84 |
| 2021-03-31 | $106k | 45k | 2.36 |
| 2020-12-31 | $79k | 45k | 1.76 |
| 2020-09-30 | $42k | 45k | 0.93 |
| 2020-06-30 | $61k | 70k | 0.87 |
| 2020-03-31 | $37k | 45k | 0.82 |
| 2019-12-31 | $40k | 45k | 0.89 |
| 2019-09-30 | $44k | 45k | 0.98 |
More positions owned by Beirne Wealth Consulting Services
View all positions for Beirne Wealth Consulting Services